Yaşa bağlı makular dejenerasyonu olan hastaların beslenme durumlarının değerlendirilmesi

Yıl 2018, Cilt: 9 Sayı: 1, 20 - 27, 17.04.2018

Mustafa Özgür , Aslı Uçar

https://doi.org/10.22312/sdusbed.368758

Cited By: 1

Öz

Amaç: Bu araştırmada makular dejenerasyonu olan
bireylerin beslenme durumunun değerlendirilmesi amaçlanmıştır.

Materyal-Metod: Araştırma, Ankara Üniversitesi Vehbi Koç
Göz Hastanesine başvuran ve herhangi bir göz hastalığı olan bireyler üzerinde
yapılmıştır. Çalışma Yaşa Bağlı Makular Dejenerasyonu (YBMD) olan (erkek:46;
kadın:29; toplam:75) ve olmayan (erkek:48; kadın:26; toplam:76) toplam 151
hasta ile yürütülmüştür.

Bulgular: Çalışmaya katılan bireylerin %62,3’ü
erkek, %37,7’si kadındır Çalışmaya katılan bireylerden YBMD’si olanların
%26,7’si, kontrol grubunun %30,3’ü yetersiz enerji; YBMD’si olanların %14,7’si,
kontrol grubunun %15,8’i yetersiz karbonhidrat; YBMD’si olanların %30,7’si,
kontrol grubunun %28,9’u yetersiz protein ve YBMD’si olanların %64,0’ü, kontrol
grubunun %53,9’u yetersiz miktarda posa almaktadır.

Sonuç: Sonuç olarak bazı makro ve mikro besin
ögesi alımları ile hastalığın seyri arasında ilişki bulunmuştur. Ancak, makular
dejenerasyonu olan hastalara beslenme önerilerinde bulunmak için yaşam boyu
beslenmelerinin sorgulandığı uzun süreli çalışmalara ihtiyaç vardır.

Anahtar Kelimeler

Beslenme alışkanlığı, Makular dejenerasyon, Yaşlı beslenmesi

Kaynakça

• Kutsal YG. Neden geriatri. Turk J Phys Med Rehab 2000; 13:39-42.
• World Health Organization (WHO). Definition of an older or elderly person Erişim Tarihi: 22 Mayıs 2013. Erişim Adresi: http://www.who.int/healthinfo/survey/ageingdefnolder/en/.
• Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health 2005; 4(1): 2.
• Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995; 39(5): 367-374.
• Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet 2012; (379): 1728-1738.
• Haab O. Erkrankungen der macula lutea. Zentralbl Augenheilkd 1885 ;9: 384-391.
• Gorin MB, Chew E, and Clemons E. Long-term effects of vitamins c, e, beta-carotene and zinc on age-related macular degeneration. AREDS Report No. 35. Ophtalmology 2013; 12(8): 1604-16111.
• Merle BM, Silver RE, Rosner B, Seddon JM. Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study. Am J Clin Nutr 2016; 103(4): 1135-1144.
• Crabb JW, Miyagi M, Gu X, Shandrach K, West K, Sagakuchi AH, et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. PNAS 2002; 99(23): 14682-14687.
• The Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122(4): 564-572.
• Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the national health and nutrition examination survey III. Ophthalmology 1999; 106(6): 1056-1065.
• Mitchell P, Smith W, Attebo K, Wang JJ. Pevalence of age-related maculopathy in Australia. the blue mountains eye study. Ophthalmology 1995; 102(10): 1450-1460.
• Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, et al. The prevalence of age-related maculopathy in the rotterdam study. Ophthalmology 1995; 102(2): 205-210.
• Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the beaver dam eye study. Ophthalmology 1997; 104(1); 7-21.
• Klein R, Cruickshanks KJ, Nash, SD, Krantz EM, Nieto FJ, Huang GH, et al. The prevalence of age-related macular degeneration and associated risk factors. JAMA Ophthalmol 2010; 128(6): 750-758.
• Saksens NT, Fleckenstein M, Schmitz-Valckenberg S, Holz FG, den Hollander AI, Keunen JE, et al. Macular dystrophies mimicking age-related macular degeneration. Prog Retin Eye Res 2014; 39; 23-57. Vanderbeek BL, Zacks DN, Talwar N, Nan B, Musch DC, Stein JD. Racial differences in age-related macular degeneration rates in the united states: a longitudinal analysis of a managed care network. AJO 2011; 152(2): 273-282.
• Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS). AREDS Report No. 19. Ophthalmology 2005; 112(4): 533-539.
• Fraser-Bell S, Wu J, Klein R, Azen SP, Hooper C, Foong AW, et al. Cardiovascular risk factors and age-related macular degeneration: the los angeles latino eye study. Am J Ophthalmol 2008; 145(2): 308-316.
• Chen X, Rong SS, Xu Q, Tang FY, Liu Y, Gu H, et al. Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis,» PloS One 2014; 9(6): e108196.
• Garcia PM, Marin-Castaño ME. Angiotensin II-related hypertension and eye diseases. WJC 2014; 6(9): 968.
• Sobrin L, Seddon JM. Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog Retin Eye Res 2014; 40: 1-15.
• Özgür M, Yabancı Ayhan N. Yaşa bağlı makular dejenerasyon ve beslenme. Sağlık Bilimleri Dergisi 2016; 25(3): 161-164.
• Millen AE, Voland R, Sondel SA, Parekh N, Horst RL, Wallace RB, et al. Vitamin d status and early age-related macular degeneration in postmenopausal women. Epidemiology 2011; 129(4): 481-489.
• Christen WG, Schaumberg DA, Glynn RJ, Buring JE. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch. Ophthalmol 2011; 129(7): 921-929.
• Akuffo KO, Nolan JM., Howard AN, Moran R, Stack J, Klein R, et al. Sustained supplementation and monitored response with differing carotenoid 16 formulations in early age-related macular degeneration. Eye 2015; 29(7): 902-912.
• De Velasco PC, Sandre PC, Tavares Do Carmo MG, Faria-Melibeu AC, Campello-Costa P, Ferraz AC, et al. A critical period for omega-3 nutritional supplementation in the development of the rodent visual system. Brain Research 2015; 1615: 106-115.
• Gorusupudi A, Nelson K, Bernstein PS. The age-related eye disease 2 study: micronutrients in the treatment of macular degeneration. Advances in Nutrition: An International Review Journal 2017; 8(1): 40-53.
• Eisenhauer B, Natoli S, Liew G, Flood VM. Lutein and zeaxanthin—food sources, bioavailability and dietary variety in age‐related macular degeneration protection. Nutrients, 2017; 9(pii): 120.
• Wu J, Cho E, Giovannucci EL, Rosner BA, Sastry SM, Willett WC, et al. Dietary ıntakes of eicosapentaenoic acid and docosahexaenoic acid and risk of age-related macular degeneration. Ophthalmology 2017.
• Rakıcıoğlu N, Tek AN, Ayaz A, Pekcan G. Yemek ve besin fotoğraf kataloğu ölçü ve miktarlar, HÜ BvD. Bölümü Ankara: Ata Ofset Matbaacılık 2014
• Merdol TK. Standart yemek tarifeleri. Ankara 2003: Hatipoğlu Yayınevi.
• Gibson RS. Principles of nutritional assessment. 2nd Edt. New York, Oxford University Press, 2005; p. 324-328.
• Gopinath B, Liew G, Russell J, Cosatto V, Burlutsky G, Mitchell P. Intake of key micronutrients and food groups in patients with late-stage age-related macular degeneration compared with age-sex-matched controls. Br J Ophthalmol 2016; 101(8): 1027-1031.
• Munch IC, Toft U, Linneberg A, Larsen M. Precursors of age-related macular degeneration: associations with vitamin A and interaction with CFHY402H in the eye study. Acta Ophthalmol 2016; 94(7): 657-662.
• Seddon JM, Silver RE, Rosner B. Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis. Br J Ophthalmol 2016; 100(12): 1731-1737.
• McGuinness MB, Karahalios A, Kasza J, Guymer RH, Finger RP, Simpson JA. Survival bias when assessing risk factors for age-related macular degeneration: a tutorial with application to the exposure of smoking. Ophthalmic Epidemiol 2017; 13: 1-10.
• Srinivasan S, Swaminathan G, Kulothungan V, Raman R, Sharma T. Prevalence and the risk factors for visual impairment in age-related macular degeneration. Eye 2017; 31: 846-855.
• Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC ophthalmology 2010; 10(1): 31-44.
• Chua J, Lim B, Fenwick EK., Gan AT, Tan AG, Lamoureux E, et al. Prevalence, risk factors, and ımpact of undiagnosed visually significant cataract: the singapore epidemiology of eye diseases study. PLoS One 2017; 12(1): e0170804.
• TC Sağlık Bakanlığı. Türkiye beslenme rehberi 2015. Ankara, 2016.
• Cho SS, Qi L, Fahey Jr GC, Klurfeld DM. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. ASN 2013; no. ajcn-067629.
• Biggelaar LJ, Eussen SJ, Sep SJ, Mari A, Ferrannini E, Dongen MC, et al. Associations of dietary glucose, fructose, and sucrose with β-cell function, ınsulin sensitivity, and type 2 diabetes in the maastricht study. Nutrients 2017; 9(4): 380.
• Krogh K, Chiarioni G, Whitehead W. Management of chronic constipation in adults. United European Gastroenterol J 2017; 5(4): 465-472.
• Narita S, Inoue M, Saito E, Abe SK, Sawada N, Ishihara J, et al. Dietary fiber intake and risk of breast cancer defined by estrogen and progesterone receptor status: the Japan public health center-based prospective study CCC 2017; 28(6): 569-578.
• Micha R, Khatibzdeh S, Shi P, Fahimi S, Lim S, Andrews KG, et al. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ 2014; 348: g2272.
• Larsen J, Boeckner L. Omega-3 fatty acids. Erişim Tarihi: 27 Haziran 2006. Erişim Adresi: http://www.ianrpubs.unl.edu/epublic/pages/publicationD.jsp?publication.
• Baysal A. Beslenme. 15’nci basım, Ankara, Hatipoğlu Yayınları, 2014.
• Jyväkorpi SK, Pitkälä KH, Pitkälä TM, Björkman MP, Kautiainen H, Strandberg TE, et al. High proportions of older people with normal nutritional status have poor protein intake and low diet quality archives of gerontology and geriatrics. Arch Gerontol Geriatr 2016; 67: 40-45.
• Van Wymelbeke V, Brondel L, Bon F, Martin-Pfitzenmeyer I, Manckoundia P. An innovative brioche enriched in protein and energy improves the nutritional status of 19 malnourished nursing home residents compared to oral nutritional supplement and usual breakfast: FARINE+ Project. Clinical Nutrition ESPEN 2016; 15: 93-100.
• Zhao L-G, Shu X-O, Shu H-L, Zhang W, Gao J, Sun J-W, et al. Dietary antioxidant vitamins intake and mortality: A report from two cohort studies of Chinese adults in Shanghai. Journal of Epidemiology 2017; 27: 89-97.
• Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging 2006; 10(5): 377-385.
• Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: can we reconcile the evidence? PLEFA, 2013; 88(1) : 61-70.
• Mohajeri MH, Troesch B, Weber P. Inadequate supply of vitamins and DHA in the elderly:Implications for brain aging and Alzheimer-type dementia. Nutrition 2015; 31: 261-275.
• Bolzetta F, Veronese N, Rui M, Berton L, Toffanello ED, Carraro S, et al. Are the recommended dietary allowances for vitamins appropriate for elderly people. Journal of the Academy of Nutrition and Dietetics 2015; 115(11): 1789-1797.
• Jin Y, Xi C, Qin J, Preedy VR, Yong J. Vitamin D and age-related macular degeneration, In Handbook of Nutrition, Diet and the Eye , 2014, 339-348